StockData
Alamar Biosciences, Inc. logo

Alamar Biosciences, Inc. (ALMR) KPIs and segments

ALMRNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026
$30.64+0.09 (+0.29%)

Close on Nov 17, 2026Market cap $2.13BP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Alamar Biosciences's business

Alamar Biosciences's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.

The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.

Add to chartMetric
Q2 2026
Q1 2026
Q2 2025
Q1 2025
Product Revenue($M)
23.321.312.09.17
Consumables($M)
15.514.06.275.02
Instruments($M)
7.797.385.774.15
Service and Other Revenue($M)
6.164.694.123.92
Services($M)
6.164.694.123.67
Other revenue($M)
00.25
United States($M)
19.714.99.529.47
Europe, Middle East and Africa($M)
6.583.973.951.42
United Kingdom($M)
3.461.73
Asia Pacific($M)
2.692.412.320.45
Americas (excluding United States)($M)
0.501.290.360.02
Product Revenue($M)
13.411.55.553.80
Service and Other Revenue($M)
4.312.933.032.59

Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).

Methodology and excluded metrics
  • Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).

Data updated 2026-08-11.

See a number that looks wrong?